trending Market Intelligence /marketintelligence/en/news-insights/trending/dzvmlbTlbYSKQ-IB6y205g2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Novelion Therapeutics appoints CFO

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Novelion Therapeutics appoints CFO

Novelion Therapeutics Inc. appointed Michael Price as CFO and senior vice president, effective Dec. 4.

Price joins Novelion from Noven Pharmaceuticals Inc., where he served as vice president and CFO.

Gregory Perry has resigned as CFO of Novelion to pursue other opportunities, and will remain with the company until Dec. 31 to enable an effective transition.